查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1698135

膈肌起搏治療系統市場－全球產業規模、佔有率、趨勢、機會和預測（按產品、應用、地區和競爭細分，2020-2030 年）

Diaphragm Pacing Therapy System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球橫膈膜起搏治療系統市場價值為 77.1 億美元，預計在預測期內將實現令人印象深刻的成長，到 2030 年的複合年成長率為 4.06%。近年來，全球膈肌起搏治療系統市場穩步成長，推動因素包括呼吸系統疾病患病率上升、醫療設備技術進步以及人們對膈肌起搏作為某些患者群體替代療法的認知不斷提高。例如，在歐洲，呼吸系統疾病是歐洲環境署成員國第三大死因。每年有近 42 萬人死於呼吸系統疾病，其中 60% 以上與慢性呼吸道疾病 (CRD) 有關（Eurostat，2024a；WHO，2024；IHME，2024）。雖然某些國家因呼吸系統疾病導致的死亡率和疾病負擔較高，但尚未發現一致的區域模式。

市場概覽
預測期 2026-2030
2024年市場規模 77.1億美元
2030年市場規模 97.1億美元
2025-2030 年複合年成長率 4.06%
成長最快的領域 脊髓損傷
最大的市場 北美洲

關鍵市場促進因素

呼吸系統疾病盛行率上升

主要市場挑戰

初始成本高

主要市場趨勢

增強型設備技術

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球橫膈膜起搏治療系統市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品（體外橫膈膜起搏器、橫膈膜起搏器）
    • 依應用（脊髓損傷、肌萎縮側索硬化症、其他）
    • 按地區
    • 按公司分類（2024）
  • 產品市場圖
    • 按產品
    • 按應用
    • 按地區

第6章：北美橫膈膜起搏治療系統市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 加拿大
    • 墨西哥

第7章：歐洲橫膈膜起搏治療系統市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 英國
    • 法國
    • 義大利
    • 西班牙

第8章：亞太橫膈肌起搏治療系統市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 日本
    • 印度
    • 澳洲
    • 韓國

第9章：南美橫膈膜起搏治療系統市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章：中東與非洲橫膈膜起搏治療系統市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • LUNGPACER MEDICAL INC.
  • Avery Biomedical Devices, Inc.
  • Synapse Biomedical Inc
  • Astrotech Corp
  • AstraZeneca PLC
  • Novartis AG
  • Boehringer Ingelheim
  • Respironics Ltd
  • Johnson & Johnson (Actelion)
  • PneumRx, LLC

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 20597

Global Diaphragm Pacing Therapy System Market was valued at USD 7.71 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.06% through 2030. The Global Diaphragm Pacing Therapy System Market has witnessed steady growth in recent years, driven by factors such as the rising prevalence of respiratory disorders, technological advancements in medical devices, and increasing awareness about diaphragm pacing as an alternative therapy for certain patient populations. For instance, in Europe, respiratory disorders rank as the third leading cause of death in European Environment Agency member countries. Annually, nearly 420,000 deaths are attributed to respiratory diseases, with over 60% linked to Chronic Respiratory Diseases (CRDs) (Eurostat, 2024a; WHO, 2024; IHME, 2024). While certain countries experience higher mortality and disease burden from respiratory conditions, no consistent regional pattern has been identified.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 7.71 Billion
Market Size 2030USD 9.71 Billion
CAGR 2025-20304.06%
Fastest Growing SegmentSpinal Cord Injury
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Respiratory Disorders

The global healthcare landscape is witnessing a significant shift, with a concerning increase in the prevalence of respiratory disorders. These conditions can significantly impair an individual's ability to breathe, leading to a reduced quality of life and, in severe cases, life-threatening situations. However, amidst these challenges, there is a glimmer of hope for patients in the form of diaphragm pacing therapy systems. As the prevalence of respiratory disorders continues to rise, the diaphragm pacing therapy system market is poised for substantial growth. According to WHO, chronic obstructive pulmonary disease (COPD) claims over 3 million lives annually, silently impacting more than 380 million people worldwide. As the fourth leading cause of death globally, COPD has remained underrepresented in global health discussions, despite its profound effects on patients and families. It's time to bring this noncommunicable disease to the forefront and address its devastating impact.

Key Market Challenges

High Initial Costs

One of the most prominent challenges in the diaphragm pacing therapy system market is the high initial costs associated with these devices. The sophisticated technology and intricate surgical procedures required for implantation can result in substantial expenses for both healthcare facilities and patients. The cost may act as a deterrent, limiting access to those who may benefit from diaphragm pacing therapy.

Key Market Trends

Enhanced Device Technology

One of the most prominent trends in the diaphragm pacing therapy system market is the ongoing enhancement of device technology. Manufacturers are investing in research and development to create more advanced, efficient, and patient-friendly systems. This includes devices with improved battery life, wireless connectivity for remote monitoring, and more compact designs for enhanced comfort.

Key Market Players

  • LUNGPACER MEDICAL INC.
  • Avery Biomedical Devices, Inc.
  • Synapse Biomedical Inc
  • Astrotech Corp.
  • AstraZeneca PLC
  • Novartis AG
  • Boehringer Ingelheim
  • Respironics Ltd
  • Johnson & Johnson (Actelion)
  • PneumRx, LLC

Report Scope:

In this report, the Global Diaphragm Pacing Therapy System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diaphragm Pacing Therapy System Market, By Product:

  • External Diaphragm Pacemaker
  • Diaphragm Pacemaker

Diaphragm Pacing Therapy System Market, By Application:

  • Spinal Cord Injury
  • Amyotrophic Lateral Sclerosis
  • Others

Diaphragm Pacing Therapy System Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Diaphragm Pacing Therapy System Market.

Available Customizations:

Global Diaphragm Pacing Therapy System market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diaphragm Pacing Therapy System Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
    • 5.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Product
    • 5.3.2. By Application
    • 5.3.3. By Region

6. North America Diaphragm Pacing Therapy System Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
    • 6.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Diaphragm Pacing Therapy System Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Diaphragm Pacing Therapy System Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Diaphragm Pacing Therapy System Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application

7. Europe Diaphragm Pacing Therapy System Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
    • 7.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Diaphragm Pacing Therapy System Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Diaphragm Pacing Therapy System Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
    • 7.3.3. France Diaphragm Pacing Therapy System Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Diaphragm Pacing Therapy System Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Diaphragm Pacing Therapy System Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application

8. Asia-Pacific Diaphragm Pacing Therapy System Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
    • 8.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Diaphragm Pacing Therapy System Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
    • 8.3.2. Japan Diaphragm Pacing Therapy System Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
    • 8.3.3. India Diaphragm Pacing Therapy System Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
    • 8.3.4. Australia Diaphragm Pacing Therapy System Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
    • 8.3.5. South Korea Diaphragm Pacing Therapy System Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application

9. South America Diaphragm Pacing Therapy System Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
    • 9.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Diaphragm Pacing Therapy System Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Diaphragm Pacing Therapy System Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Diaphragm Pacing Therapy System Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application

10. Middle East and Africa Diaphragm Pacing Therapy System Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
    • 10.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Diaphragm Pacing Therapy System Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Diaphragm Pacing Therapy System Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Diaphragm Pacing Therapy System Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
    • 10.3.4. Kuwait Diaphragm Pacing Therapy System Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. LUNGPACER MEDICAL INC.
  • 14.2. Avery Biomedical Devices, Inc.
  • 14.3. Synapse Biomedical Inc
  • 14.4. Astrotech Corp
  • 14.5. AstraZeneca PLC
  • 14.6. Novartis AG
  • 14.7. Boehringer Ingelheim
  • 14.8. Respironics Ltd
  • 14.9. Johnson & Johnson (Actelion)
  • 14.10. PneumRx, LLC

15. Strategic Recommendations

16. About Us & Disclaimer